(Q35956610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Paz Toren

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sharon Ratner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Nathaniel Laor

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1135-1156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15554747%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-200427140-00005

5 January 2020

exact match

0 references

cites work

Haloperidol in schizophrenic children: early findings from a study in progress

1 reference

12 December 2020

Childhood-onset schizophrenia: an NIMH study in progress.

1 reference

12 December 2020

Clozapine and cognitive function.

1 reference

12 December 2020

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

1 reference

12 December 2020

A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients

1 reference

12 December 2020

Risperidone in children with schizophrenia -letter-

1 reference

12 December 2020

Case study: risperidone-induced hepatotoxicity in pediatric patients

1 reference

12 December 2020

Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison

1 reference

12 December 2020

Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia

1 reference

12 December 2020

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

12 December 2020

Do we need placebos to evaluate new drugs in children with schizophrenia?

1 reference

12 December 2020

Use of clozapine in a child with treatment-resistant schizophrenia

1 reference

12 December 2020

A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders

1 reference

12 December 2020

Clozapine treatment in an adolescent with bipolar disorder.

1 reference

12 December 2020

Risperidone-associated galactorrhea in a male teenager

1 reference

12 December 2020

Clozapine for the treatment of adolescents with schizophrenia

1 reference

12 December 2020

Can diabetes mellitus be induced by medication?

1 reference

12 December 2020

Eosinophilia, clozapine, and pancreatitis

1 reference

12 December 2020

Olanzapine in Tourette's disorder

1 reference

12 December 2020

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

1 reference

12 December 2020

Pilot evaluation of Orap (pimozide, R 6238) in child psychiatry

1 reference

12 December 2020

A double-blind pilot study of risperidone in the treatment of conduct disorder

1 reference

12 December 2020

Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.

1 reference

12 December 2020

Quetiapine-associated hyperglycemia and hypertriglyceridemia

1 reference

12 December 2020

A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial

1 reference

12 December 2020

1 reference

12 December 2020

Agranulocytosis in a child with schizophrenia treated with clozapine--clinical findings and therapy, a case report

1 reference

12 December 2020

Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study

1 reference

12 December 2020

Olanzapine usage associated with neuroleptic malignant syndrome.

1 reference

12 December 2020

Ziprasidone-associated galactorrhea in a female teenager

1 reference

12 December 2020

Quetiapine for refractory mania in a child.

1 reference

12 December 2020

Olanzapine treatment of eight adolescent patients with psychosis

1 reference

12 December 2020

A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder

1 reference

12 December 2020

Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders

1 reference

12 December 2020

Olanzapine in the treatment of adolescent acute mania: a report of seven cases

1 reference

12 December 2020

Treatment of childhood-onset schizophrenia with olanzapine

1 reference

12 December 2020

The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia

1 reference

12 December 2020

Use of atypical antipsychotics in mood disorders.

1 reference

12 December 2020

Risperidone-associated weight gain in children and adolescents: a retrospective chart review

1 reference

12 December 2020

Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol

1 reference

12 December 2020

Clozapine treatment in very early onset schizophrenia

1 reference

12 December 2020

Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study

1 reference

12 December 2020

Prolactin levels in young children with pervasive developmental disorders during risperidone treatment.

1 reference

12 December 2020

Aripiprazole in an adult with Asperger disorder

1 reference

12 December 2020

Risperidone in the treatment of schizophrenia

1 reference

12 December 2020

Use of atypical neuroleptics in child and adolescent psychiatry.

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

1 reference

12 December 2020

Clinical experience with risperidone

1 reference

12 December 2020

Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.

1 reference

12 December 2020

Diabetic ketoacidosis associated with olanzapine in an adolescent patient

1 reference

12 December 2020

Clozapine in the treatment of a young adolescent with schizophrenia

1 reference

12 December 2020

Open-label quetiapine in the treatment of children and adolescents with autistic disorder.

1 reference

12 December 2020

Triglyceride, cholesterol and weight changes among risperidone-treated youths. A retrospective study

1 reference

12 December 2020

Clozapine-associated elevation in serum triglycerides

1 reference

12 December 2020

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness

1 reference

12 December 2020

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

1 reference

12 December 2020

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

12 December 2020

Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial

1 reference

12 December 2020

Update and recommendations for the use of antipsychotics in early-onset psychoses

1 reference

12 December 2020

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

1 reference

12 December 2020

1 reference

12 December 2020

Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label study

1 reference

12 December 2020

Development of obsessive-compulsive symptoms during clozapine treatment

1 reference

12 December 2020

Depression and dysphoria in adult and adolescent patients with Tourette's disorder treated with risperidone

1 reference

12 December 2020

Mood stabilizer augmentation with olanzapine in acutely manic children

1 reference

12 December 2020

Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder

1 reference

12 December 2020

Risperidone for young children with mood disorders and aggressive behavior

1 reference

12 December 2020

Clozapine, neuroleptic malignant syndrome, and pancerebellar syndrome

1 reference

12 December 2020

Olanzapine induces remarkable weight gain in adolescent patients

1 reference

12 December 2020

Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases

1 reference

12 December 2020

Risperidone side effects

1 reference

12 December 2020

Risperidone for treatment of childhood schizophrenia

1 reference

12 December 2020

Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic

1 reference

12 December 2020

Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases

1 reference

12 December 2020

Ziprasidone: pharmacology, clinical progress and therapeutic promise

1 reference

12 December 2020

Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication

1 reference

12 December 2020

The efficacy of olanzapine, as needed, to treat acute agitation in juveniles

1 reference

12 December 2020

Clozapine treatment of bipolar disorder in a young adolescent

1 reference

12 December 2020

Antipsychotics in children and adolescents

1 reference

12 December 2020

Risperidone treatment of a psychotic adolescent

1 reference

12 December 2020

Risperidone treatment for juvenile bipolar disorder: a retrospective chart review

1 reference

12 December 2020

A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities

1 reference

12 December 2020

Blood biogenic amines during clozapine treatment of early-onset schizophrenia.

1 reference

12 December 2020

Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent

1 reference

12 December 2020

Clozapine impact on clinical outcomes and aggression in severely ill adolescents with childhood-onset schizophrenia

1 reference

12 December 2020

Risperidone for negative symptoms

1 reference

12 December 2020

Treatment of bipolar I disorder in an adolescent with olanzapine

1 reference

12 December 2020

Open-label olanzapine treatment in five preadolescent children

1 reference

12 December 2020

Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia

1 reference

12 December 2020

Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases

1 reference

12 December 2020

Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label study

1 reference

12 December 2020

Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

1 reference

12 December 2020

Metformin for weight loss in pediatric patients taking psychotropic drugs

1 reference

12 December 2020

Quetiapine for refractory schizophrenia.

1 reference

12 December 2020

1 reference

12 December 2020

Hyperglycemia and hypertriglyceridemia secondary to olanzapine

1 reference

12 December 2020

Paediatric uses of atypical antipsychotics

1 reference

12 December 2020

Risperidone in adolescents with schizophrenia: an open pilot study

1 reference

12 December 2020

Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia

1 reference

12 December 2020

Case series: use of ziprasidone for maladaptive symptoms in youths with autism

1 reference

12 December 2020

Treatment of risperidone-induced hyperprolactinemia with a dopamine agonist in children

1 reference

12 December 2020

Mania associated with olanzapine

1 reference

12 December 2020

An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia

1 reference

12 December 2020

Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine

1 reference

12 December 2020

An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia.

1 reference

12 December 2020

1 reference

12 December 2020

Risperidone in childhood schizophrenia

1 reference

12 December 2020

Enuresis with combined risperidone and SSRI use.

1 reference

12 December 2020

A prospective, open-label trial of olanzapine in adolescents with schizophrenia

1 reference

12 December 2020

Effect of clozapine in severe tardive dyskinesia: a case report

1 reference

12 December 2020

Tolerability profile of atypical antipsychotics in children and adolescents

1 reference

12 December 2020

Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.

1 reference

12 December 2020

Separation anxiety in children and adolescents treated with risperidone

1 reference

12 December 2020

Clozapine for schizophrenia

1 reference

12 December 2020

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review.

1 reference

12 December 2020

Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome

1 reference

12 December 2020

A study of quetiapine: efficacy and tolerability in psychotic adolescents

1 reference

12 December 2020

Effects of development on olanzapine-associated adverse events

1 reference

12 December 2020

[Results of treatment with clozapine in schizophrenic adolescents]

1 reference

12 December 2020

Clozapine for tardive dyskinesia in adolescents.

1 reference

12 December 2020

Risperidone-induced hepatotoxicity in children and adolescents? A chart review study

1 reference

12 December 2020

Aripiprazole and extrapyramidal symptoms

1 reference

12 December 2020

Case study: risperidone in children and adolescents with schizophrenia

1 reference

12 December 2020

Atypical antipsychotic drugs and hyperglycemia in adolescents

1 reference

12 December 2020

Experience with ziprasidone

1 reference

12 December 2020

Clozapine for schizophrenia

1 reference

12 December 2020

Improvement of some schizophrenic deficit symptoms with low doses of amisulpride

1 reference

12 December 2020

The relevance of prolonged QTc measurement to pediatric psychopharmacology

1 reference

12 December 2020

Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study

1 reference

12 December 2020

Risperidone in children with autism and serious behavioral problems

1 reference

12 December 2020

A 1-year open-label trial of olanzapine in school-age children with schizophrenia

1 reference

12 December 2020

Risperidone-induced neuroleptic malignant syndrome

1 reference

12 December 2020

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment

1 reference

12 December 2020

Risperidone and tardive dyskinesia

1 reference

12 December 2020

Risperidone in the treatment of two very young children with autism.

1 reference

12 December 2020

Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD)

1 reference

12 December 2020

[Own experiences (1989-1994) in the treatment of adolescent schizophrenic paranoid syndromes with Leponex produced by Sandoz company]

1 reference

12 December 2020

Quetiapine in adolescent psychosis

1 reference

12 December 2020

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

1 reference

12 December 2020

Management of schizophrenia in children and adolescents. The role of clozapine

1 reference

12 December 2020

Clozapine in the treatment of aggression in an adolescent with autistic disorder

1 reference

12 December 2020

Trihexyphenidyl treatment of clozapine-induced hypersalivation

1 reference

12 December 2020

Is liver function monitoring warranted during risperidone treatment?

1 reference

12 December 2020

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine

1 reference

12 December 2020

Risperidone may worsen fluoxetine-treated OCD.

1 reference

12 December 2020

Differential response of psychotic and obsessive symptoms to risperidone in an adolescent

1 reference

12 December 2020

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

1 reference

12 December 2020

Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents

1 reference

12 December 2020

Long-term remission of schizophrenia in an adolescent treated with quetiapine

1 reference

12 December 2020

Risperidone in adolescents

1 reference

12 December 2020

Risperidone in the treatment of children and adolescents with schizophrenia: a retrospective study

1 reference

12 December 2020

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism

1 reference

12 December 2020

Olanzapine and hypertriglyceridemia

1 reference

12 December 2020

Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study

1 reference

12 December 2020

Tics with risperidone withdrawal

1 reference

12 December 2020